Your browser doesn't support javascript.
loading
Effects of combined therapy of valsartan and rosuvastatin on patients with atrial fibrillation.
Hu, W M; Shi, Z H; Wu, D Y; Ye, S Y; Xiang, Y J; Liu, C; Chen, J C; Zeng, C L.
Affiliation
  • Hu WM; Department of Cardiology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China.
  • Shi ZH; Department of Cardiology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China.
  • Wu DY; Department of Cardiology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China.
  • Ye SY; Department of Cardiology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China.
  • Xiang YJ; Department of Cardiology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China.
  • Liu C; Department of Cardiology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China.
  • Chen JC; Department of Cardiology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China.
  • Zeng CL; Department of Cardiology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China.
J Biol Regul Homeost Agents ; 34(6): 2215-2220, 2020.
Article in En | MEDLINE | ID: mdl-33185084
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Valsartan Limits: Humans Language: En Journal: J Biol Regul Homeost Agents Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Valsartan Limits: Humans Language: En Journal: J Biol Regul Homeost Agents Year: 2020 Document type: Article